Literature DB >> 21930233

New insights into the biological effects of anthrax toxins: linking cellular to organismal responses.

Annabel Guichard1, Victor Nizet, Ethan Bier.   

Abstract

The anthrax toxins lethal toxin (LT) and edema toxin (ET) are essential virulence factors produced by Bacillus anthracis. These toxins act during two distinct phases of anthrax infection. During the first, prodromal phase, which is often asymptomatic, anthrax toxins act on cells of the immune system to help the pathogen establish infection. Then, during the rapidly progressing (or fulminant) stage of the disease bacteria disseminate via a hematological route to various target tissues and organs, which are typically highly vascularized. As bacteria proliferate in the bloodstream, LT and ET begin to accumulate rapidly reaching a critical threshold level that will cause death even when the bacterial proliferation is curtailed by antibiotics. During this final phase of infection the toxins cause an increase in vascular permeability and a decrease in function of target organs including the heart, spleen, kidney, adrenal gland, and brain. In this review, we examine the various biological effects of anthrax toxins, focusing on the fulminant stage of the disease and on mechanisms by which the two toxins may collaborate to cause cardiovascular collapse. We discuss normal mechanisms involved in maintaining vascular integrity and based on recent studies indicating that LT and ET cooperatively inhibit membrane trafficking to cell-cell junctions we explore several potential mechanisms by which the toxins may achieve their lethal effects. We also summarize the effects of other potential virulence factors secreted by B. anthracis and consider the role of toxic factors in the evolutionarily recent emergence of this devastating disease.
Copyright © 2011 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21930233      PMCID: PMC3743078          DOI: 10.1016/j.micinf.2011.08.016

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  181 in total

Review 1.  Rap1, a mercenary among the Ras-like GTPases.

Authors:  E W Frische; F J T Zwartkruis
Journal:  Dev Biol       Date:  2010-01-07       Impact factor: 3.582

2.  Sepsis and pathophysiology of anthrax in a nonhuman primate model.

Authors:  Deborah J Stearns-Kurosawa; Florea Lupu; Fletcher B Taylor; Gary Kinasewitz; Shinichiro Kurosawa
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

3.  Studies on infection with Bacillus anthracis; the immunological and tissue damaging properties of extracts prepared from lesions of B. anthracis infections.

Authors:  W J CROMARTIE; D W WATSON
Journal:  J Infect Dis       Date:  1947 Jan-Feb       Impact factor: 5.226

4.  The Ral/exocyst effector complex counters c-Jun N-terminal kinase-dependent apoptosis in Drosophila melanogaster.

Authors:  Maria Balakireva; Carine Rossé; Johanna Langevin; Yu-chen Chien; Michel Gho; Geneviève Gonzy-Treboul; Stéphanie Voegeling-Lemaire; Sandra Aresta; Jean-Antoine Lepesant; Yohanns Bellaiche; Michael White; Jacques Camonis
Journal:  Mol Cell Biol       Date:  2006-09-25       Impact factor: 4.272

5.  Suppression of dendritic cell activation by anthrax lethal toxin and edema toxin depends on multiple factors including cell source, stimulus used, and function tested.

Authors:  Ping-Jen Joe Chou; Catherine A Newton; Izabella Perkins; Herman Friedman; Thomas W Klein
Journal:  DNA Cell Biol       Date:  2008-12       Impact factor: 3.311

6.  Susceptibility to anthrax lethal toxin-induced rat death is controlled by a single chromosome 10 locus that includes rNlrp1.

Authors:  Zachary L Newman; Morton P Printz; Shihui Liu; Devorah Crown; Laura Breen; Sharmina Miller-Randolph; Pamela Flodman; Stephen H Leppla; Mahtab Moayeri
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

7.  Bacillus anthracis edema toxin impairs neutrophil actin-based motility.

Authors:  Sarah E Szarowicz; Russell L During; Wei Li; Conrad P Quinn; Wei-Jen Tang; Frederick S Southwick
Journal:  Infect Immun       Date:  2009-04-06       Impact factor: 3.441

8.  Contribution of individual toxin components to virulence of Bacillus anthracis.

Authors:  C Pezard; P Berche; M Mock
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

9.  Spatial localization of bacteria controls coagulation of human blood by 'quorum acting'.

Authors:  Christian J Kastrup; James Q Boedicker; Andrei P Pomerantsev; Mahtab Moayeri; Yao Bian; Rebecca R Pompano; Timothy R Kline; Patricia Sylvestre; Feng Shen; Stephen H Leppla; Wei-Jen Tang; Rustem F Ismagilov
Journal:  Nat Chem Biol       Date:  2008-12       Impact factor: 15.040

10.  Anthrax lethal toxin suppresses murine cardiomyocyte contractile function and intracellular Ca2+ handling via a NADPH oxidase-dependent mechanism.

Authors:  Machender R Kandadi; Yinan Hua; Heng Ma; Qun Li; Shu-ru Kuo; Arthur E Frankel; Jun Ren
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

View more
  43 in total

1.  Key tissue targets responsible for anthrax-toxin-induced lethality.

Authors:  Shihui Liu; Yi Zhang; Mahtab Moayeri; Jie Liu; Devorah Crown; Rasem J Fattah; Alexander N Wein; Zu-Xi Yu; Toren Finkel; Stephen H Leppla
Journal:  Nature       Date:  2013-08-28       Impact factor: 49.962

2.  Micropatterned macrophage analysis reveals global cytoskeleton constraints induced by Bacillus anthracis edema toxin.

Authors:  Yannick Trescos; Emilie Tessier; Clémence Rougeaux; Pierre L Goossens; Jean-Nicolas Tournier
Journal:  Infect Immun       Date:  2015-05-26       Impact factor: 3.441

3.  HDAC8-mediated epigenetic reprogramming plays a key role in resistance to anthrax lethal toxin-induced pyroptosis in macrophages.

Authors:  Soon-Duck Ha; Chae Young Han; Chantelle Reid; Sung Ouk Kim
Journal:  J Immunol       Date:  2014-06-27       Impact factor: 5.422

4.  Global metabolomic analysis of a mammalian host infected with Bacillus anthracis.

Authors:  Chinh T Q Nguyen; Vivekananda Shetty; Anthony W Maresso
Journal:  Infect Immun       Date:  2015-10-05       Impact factor: 3.441

Review 5.  An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsis.

Authors:  Lernik Ohanjanian; Kenneth E Remy; Yan Li; Xizhong Cui; Peter Q Eichacker
Journal:  Expert Opin Investig Drugs       Date:  2015-04-28       Impact factor: 6.206

Review 6.  RAB11-mediated trafficking in host-pathogen interactions.

Authors:  Annabel Guichard; Victor Nizet; Ethan Bier
Journal:  Nat Rev Microbiol       Date:  2014-09       Impact factor: 60.633

7.  Bacillus anthracis edema but not lethal toxin challenge in rats is associated with depressed myocardial function in hearts isolated and tested in a Langendorff system.

Authors:  Yan Li; Mones Abu-Asab; Junwu Su; Ping Qiu; Jing Feng; Lernik Ohanjanian; Hanish Sampath Kumar; Yvonne Fitz; Peter Q Eichacker; Xizhong Cui
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-10       Impact factor: 4.733

8.  The Poly-γ-d-Glutamic Acid Capsule Surrogate of the Bacillus anthracis Capsule Is a Novel Toll-Like Receptor 2 Agonist.

Authors:  Jun Ho Jeon; Hae-Ri Lee; Min-Hee Cho; Ok-Kyu Park; Jungchan Park; Gi-eun Rhie
Journal:  Infect Immun       Date:  2015-07-20       Impact factor: 3.441

9.  B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring model.

Authors:  Yan Li; Xizhong Cui; Steven B Solomon; Kenneth Remy; Yvonne Fitz; Peter Q Eichacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

10.  Delineation of the Residues of Bacillus anthracis Zinc Uptake Regulator Protein Directly Involved in Its Interaction with Cognate DNA.

Authors:  Divya Kandari; Hemant Joshi; Neetu Tanwar; Manoj Munde; Rakesh Bhatnagar
Journal:  Biol Trace Elem Res       Date:  2020-10-14       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.